Caspian Healthcare › Obesity › Medicines › Oral semaglutide
This page is information, not a prescription. It describes a prescription medicine by its generic name so that you can read about it before or after a consultation. It is not an advertisement, it is not an offer to supply any medicine, and it does not recommend any brand. Nothing here should be used to start, stop or change a medicine. That decision is made by a doctor who has examined you.
The same molecule as the injection, taken as a daily tablet. No needle and no fridge. It has three real places in obesity care: the person who cannot face an injection, the person worn down by years of them, and the person who has already lost the weight on an injection and needs to hold it.
Read this before anything else. The strengths sold in India are 3 mg, 7 mg and 14 mg, all approved for type 2 diabetes. The higher strengths studied for weight loss are not available in India: the 25 mg strength approved for weight management in some other countries is not marketed here, and the 50 mg dose studied in trials was never approved anywhere. So if you are hoping for the weight results you have read about from the tablet, the dose that produced them is not on sale here. Across the PIONEER trials, 14 mg produced an average weight change of roughly 2% to 4% in people with type 2 diabetes, which is about 2 to 4 kg, not the 15% figures reported for the injection.
Identical to the injection: it acts on the GLP-1 receptor, so you feel full sooner and for longer, and the stomach empties more slowly. The tablet is absorbed poorly, which is why it needs a much larger milligram dose than the injection and why the rules below are not optional.
Absorption collapses if these are broken, and there is no partial credit.
Some Indian pharmacy websites print the wrong instruction for this tablet, saying it can be taken with or without food and with a full glass of water. That is incorrect and it contradicts the manufacturer's own prescribing information. Follow the leaflet in the box and the five rules above.
Read the section above and it would be easy to dismiss the tablet. That would be a mistake. There are three situations where it is the right answer, and in all three a tablet taken beats an injection refused or abandoned.
Fear of needles is common, it is not something a person can simply decide to stop having, and it is a perfectly good reason to be offered a tablet. If the alternative to the tablet is no treatment at all, the comparison is not tablet against injection, it is tablet against nothing. We would rather start you on something you will actually take, and revisit the question later if you want to.
Some people manage injections well for a year or two and then find they have had enough: the weekly ritual, the site soreness, the fridge, the travel planning. That is real, and it is one of the commonest reasons treatment quietly stops. Moving to a tablet is a far better outcome than stopping altogether and regaining the weight, and it is worth raising at review rather than waiting until you have already given up.
The hardest part of obesity treatment is not losing the weight, it is keeping it off. If you have reached your target on an injection, maintenance does not automatically need the same dose or the same route. Moving to a daily tablet is one way of keeping treatment going for the long run at a lower monthly cost and without the weekly injection. This has to be planned and watched: it is a change of treatment, not a taper, and some weight may come back, which is why we measure at each review and change the plan if it does.
Where it is a poor choice. Someone starting treatment whose main goal is weight loss, who could manage an injection and can afford one, will usually do better on the injection, because the tablet strengths sold in India were not designed for that job. It is also a poor choice for anyone whose morning is too rushed to keep the 30 minute gap every single day.
| When | Daily dose | What it is for |
|---|---|---|
| Weeks 1 to 4 | 3 mg | Starting dose. Not a treatment dose. |
| Weeks 5 to 8 | 7 mg | First treatment dose. |
| Week 9 onwards | 14 mg | The highest strength marketed in India. |
The same family as the injection: nausea, loose motions, constipation, vomiting, indigestion and less appetite, worst in the early weeks and after each increase. The same red flags apply, and they are listed on the injection page. Tell your doctor and anaesthetist before any surgery, endoscopy or sedation.
Roughly 2% to 4% of body weight on average at the 14 mg dose, in people with type 2 diabetes. The spread is wide because it depends heavily on what else the person is taking: about 2.3 kg when it was the only diabetes medicine (PIONEER 1) and about 3.8 kg alongside metformin (PIONEER 2). Read it as two to four kilograms, not as a percentage that sounds like the injection.
The originator tablet runs roughly ₹8,900 to ₹10,900 a month depending on strength. It was left out of the March 2026 price cut, which applied only to injectables. Indian-made oral semaglutide runs roughly ₹3,000 to ₹7,600 a month. Some products are stored below 30 degrees with no cold chain at all, which for a household with an unreliable fridge is a real advantage. Prices change, so check at the pharmacy.
Worth comparing honestly: at ₹3,000 to ₹7,600 a month for 2 to 4 kg, the cost for each kilogram lost is often higher than an Indian-made semaglutide injection at a similar or lower monthly price. The treatment options planner does that arithmetic for your own weight and budget.
Sources: The PIONEER programme, particularly PIONEER 1 and PIONEER 2, and the Indian prescribing information for oral semaglutide. Prices are indicative Indian maximum retail prices in September 2026, they change often, and they are not a quotation. No medicine is sold or supplied through this website. Reviewed on 11 September 2026 by Dr. Khizer Hussain Junaidy, Diabetologist & Bariatric Physician, Telangana State Medical Council registration no. 04937.
Every number here comes from a named, published clinical trial and is reported as what happened to the people in that trial. None of it is a result from this clinic, a prediction for you, or a promise. Trial populations are selected and individual results vary widely. The trials are named in the reference line above so that you, or any doctor, can look them up.
If you want to talk about what any of it means for your own situation, our contact details and consulting hours are at the bottom of every page in this section, and our fees are published in full on the cost page.